ProstaLund announced that the treatment platform for benign prostate enlargement, CoreTherm® Eagle has landed and is launched this weekend at the European Urology Meeting EAU in Milan. CoreTherm Eagle builds on features developed and improved over 25 years in previous CoreTherm platforms. With CoreTherm Eagle, however, there has been a significant technology and component upgrade. Among many other things, the recommended treatment endpoints, primary and secondary endpoints, have been built into the new platform, which provides increased support and simplifies for
the user while increasing patient safety. For treating urology professionals, CoreTherm Eagle will be perceived as user-friendly and simple touchscreen, a built-in computer system and a sustainable design with 25% reduction in weight. In addition, treatment data can be stored per patient, and it is also possible to download the data to a USB. CoreTherm concept in 30 seconds: Fast and effective thermotherapy treatment for benign prostate enlargement in less than 15 minutes; The patient's prostate size is rarely an obstacle to treatment being carried out Low re-treatment rates; Suitable also for old and fragile patients; Several benefits compared to surgery (TURP): lower risk for serious complications, same efficacy and indicated lower PCa risk.